BIOLIGHT(SZ:300246) Xin Lang Cai Jing·2026-01-05 05:29Group 1 - The core viewpoint of the news is that Baolait Medical Technology Co., Ltd. has seen a stock price increase of 5.31%, reaching 8.53 CNY per share, with a total market capitalization of 2.257 billion CNY as of January 5 [1] - The company, founded on June 28, 1993, and listed on July 19, 2011, specializes in the research, production, sales, and service of medical device products [1] - The main revenue composition of the company includes hemodialysis products at 77.51%, monitoring equipment at 21.39%, and other products at 1.10% [1] Group 2 - From the perspective of Baolait's top ten circulating shareholders, Citic Prudential Fund has entered the list with its multi-strategy mixed fund (LOF) A, holding 1.055 million shares, which is 0.5% of the circulating shares [2] - The fund has achieved a year-to-date return of 45.48%, ranking 1493 out of 8155 in its category [2] - The fund manager, Wang Ying, has been in the position for 8 years and 326 days, with the fund's total asset size at 4.904 billion CNY [3]